Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$3.18
-1.7%
$3.22
$2.37
$7.63
$403.41M1.26820,139 shs156,270 shs
Quanterix Corporation stock logo
QTRX
Quanterix
$5.84
-1.1%
$5.47
$4.05
$16.74
$224.05M1.05595,287 shs198,861 shs
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
$0.50
-0.1%
$0.58
$0.25
$1.40
$327.11M0.966.95 million shs2.36 million shs
Transcat, Inc. stock logo
TRNS
Transcat
$80.93
-2.7%
$82.59
$67.56
$147.12
$753.52M0.7587,770 shs25,074 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
+3.53%+1.25%+33.47%-20.83%-42.32%
Quanterix Corporation stock logo
QTRX
Quanterix
-6.35%-3.91%+21.65%-11.41%-53.91%
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
+1.21%+0.54%-0.48%-30.24%+37.17%
Transcat, Inc. stock logo
TRNS
Transcat
+3.59%+3.73%-8.95%+15.73%-30.10%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
1.7266 of 5 stars
3.12.00.00.00.04.20.0
Quanterix Corporation stock logo
QTRX
Quanterix
3.1949 of 5 stars
3.33.00.00.03.23.30.6
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
2.0911 of 5 stars
3.83.00.00.01.10.00.6
Transcat, Inc. stock logo
TRNS
Transcat
2.919 of 5 stars
3.33.00.00.02.61.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
2.20
Hold$5.6076.32% Upside
Quanterix Corporation stock logo
QTRX
Quanterix
2.50
Moderate Buy$15.60167.31% Upside
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
3.50
Strong Buy$1.55208.76% Upside
Transcat, Inc. stock logo
TRNS
Transcat
2.50
Moderate Buy$114.0040.87% Upside

Current Analyst Ratings Breakdown

Latest QTRX, TRNS, CTKB, and SENS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/25/2025
Transcat, Inc. stock logo
TRNS
Transcat
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$116.00
6/2/2025
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy$1.10
5/28/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$9.00 ➝ $7.00
5/21/2025
Transcat, Inc. stock logo
TRNS
Transcat
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$106.00 ➝ $116.00
5/13/2025
Quanterix Corporation stock logo
QTRX
Quanterix
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
5/12/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSell ➝ Sell$3.50 ➝ $3.00
5/9/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$4.00
4/30/2025
Quanterix Corporation stock logo
QTRX
Quanterix
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/30/2025
Quanterix Corporation stock logo
QTRX
Quanterix
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform$12.00 ➝ $8.00
4/10/2025
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$2.00
4/9/2025
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
(Data available from 6/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$197.05M2.04$0.04 per share89.91$3.07 per share1.03
Quanterix Corporation stock logo
QTRX
Quanterix
$137.42M1.65N/AN/A$8.57 per share0.68
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
$23.68M13.87N/AN/A$0.07 per share7.17
Transcat, Inc. stock logo
TRNS
Transcat
$278.42M2.71$4.30 per share18.81$30.82 per share2.63
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$6.02M-$0.09N/AN/A-5.71%-2.90%-2.30%8/5/2025 (Estimated)
Quanterix Corporation stock logo
QTRX
Quanterix
-$38.53M-$1.30N/AN/AN/A-36.82%-15.07%-12.26%8/6/2025 (Estimated)
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
-$60.39M-$0.11N/AN/AN/A-362.30%-842.25%-67.99%N/A
Transcat, Inc. stock logo
TRNS
Transcat
$14.52M$1.5651.8330.77N/A5.21%6.47%5.02%8/4/2025 (Estimated)

Latest QTRX, TRNS, CTKB, and SENS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/19/2025Q4 2025
Transcat, Inc. stock logo
TRNS
Transcat
$0.66$0.64-$0.02$0.48$76.40 million$77.13 million
5/12/2025Q1 2025
Quanterix Corporation stock logo
QTRX
Quanterix
-$0.69-$0.53+$0.16-$0.53$28.27 million$30.33 million
5/8/2025Q1 2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$0.04-$0.09-$0.05-$0.09$43.18 million$41.46 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/AN/AN/AN/AN/A
Quanterix Corporation stock logo
QTRX
Quanterix
N/AN/AN/AN/AN/A
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
N/AN/AN/AN/AN/A
Transcat, Inc. stock logo
TRNS
Transcat
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/A
5.62
4.95
Quanterix Corporation stock logo
QTRX
Quanterix
N/A
8.29
7.53
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
59.17
2.47
2.38
Transcat, Inc. stock logo
TRNS
Transcat
0.11
2.29
1.87

Institutional Ownership

CompanyInstitutional Ownership
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
69.46%
Quanterix Corporation stock logo
QTRX
Quanterix
86.48%
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
12.36%
Transcat, Inc. stock logo
TRNS
Transcat
98.34%

Insider Ownership

CompanyInsider Ownership
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
10.33%
Quanterix Corporation stock logo
QTRX
Quanterix
6.90%
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
4.30%
Transcat, Inc. stock logo
TRNS
Transcat
2.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
500126.66 million113.58 millionOptionable
Quanterix Corporation stock logo
QTRX
Quanterix
46038.83 million36.15 millionOptionable
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
90654.22 million573.90 millionN/A
Transcat, Inc. stock logo
TRNS
Transcat
1,2459.32 million9.10 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cytek Biosciences stock logo

Cytek Biosciences NASDAQ:CTKB

$3.18 -0.05 (-1.67%)
As of 11:41 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Quanterix stock logo

Quanterix NASDAQ:QTRX

$5.84 -0.06 (-1.08%)
As of 11:41 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Senseonics stock logo

Senseonics NYSE:SENS

$0.50 0.00 (-0.06%)
As of 11:42 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Transcat stock logo

Transcat NASDAQ:TRNS

$80.92 -2.23 (-2.68%)
As of 11:41 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.